nohealthproblemsnews.com
Home »
University of Central Florida researchers have developed a nanoparticle-based disinfectant that can continuously kill viruses on a surface for up […] Natural products, or their close derivatives, make some of our most potent medicines, among which macrocycles with their large carbon-rich […] Researchers from Japan have developed a new polysulfide donor: a chemical compound composed of chains of sulfur atoms that can […] A team of researchers, affiliated with UNIST has recently introduced a novel targeted drug delivery system that can improve the […] Bioengineers at the University of California San Diego have developed a 3D bioprinting technique that works with natural materials and […] In optogenetics, researchers use light to control protein activity. This technique allows them to alter the shape of embryonic tissue […] Bacteria are master engineers of small, biologically useful molecules. A new study in Nature Communications has revealed one of the […] Based on a protein from E. coli, scientists at Tokyo Institute of Technology have developed a fluorescent protein sensor able […] A new chemical compound with the potential to destroy hard-to-treat cancer cells has been developed and tested by scientists at […] A group of Japanese researchers has developed a technology to create a hybrid catalyst from simple-structured, commercially available rhodium and […]
Nanoparticle-based disinfectant could be a powerful weapon against pathogenic viruses
Learning from nature’s bounty: New libraries for drug discovery
Polysulfide donors strongly suppress inflammatory responses
Nanoparticle breakthrough in the fight against cancer
Easy to use 3D bioprinting technique creates lifelike tissues from natural materials
Controlling organ growth with light: Optogenetics used to drive structure changes in tissues
Unusual biosynthetic pathway offers a key to future natural product discovery
Genetically encoded sensor tracks changes in oxygen levels with very high sensitivity
Compound discovered that targets cancer cells lacking the protective p53 ‘guardian gene’
Hybrid catalyst with high enantiomer selectivity
